# Study of SOC Plus IVIG Compared to SOC Alone in the Treatment of COVID-19

> **NCT04411667** · PHASE4 · COMPLETED · sponsor: **George Sakoulas, MD** · enrollment: 34 (actual)

## Conditions studied

- Sars-CoV2

## Interventions

- **DRUG:** Octagam

## Key facts

- **NCT ID:** NCT04411667
- **Lead sponsor:** George Sakoulas, MD
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-04-28
- **Primary completion:** 2020-06-23
- **Final completion:** 2020-06-23
- **Target enrollment:** 34 (ACTUAL)
- **Last updated:** 2021-06-25

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04411667

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04411667, "Study of SOC Plus IVIG Compared to SOC Alone in the Treatment of COVID-19". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT04411667. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*